Anders Ullman - 01 Aug 2025 Form 4 Insider Report for Verona Pharma plc (VRNA)

Role
Director
Signature
/s/ Andrew Fisher, Attorney-in-fact for Anders Ullman
Issuer symbol
VRNA
Transactions as of
01 Aug 2025
Net transactions value
$0
Form type
4
Filing time
05 Aug 2025, 20:16:06 UTC
Previous filing
29 Apr 2025
Next filing
08 Oct 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Ullman Anders Director 3 MORE LONDON RIVERSIDE, LONDON, UNITED KINGDOM /s/ Andrew Fisher, Attorney-in-fact for Anders Ullman 05 Aug 2025 0001836816

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VRNA Ordinary Shares Options Exercise $0 +24,000 +7.2% $0.000000 358,856 01 Aug 2025 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VRNA Restricted Stock Units Options Exercise $0 -24,000 -25% $0.000000 72,000 01 Aug 2025 Ordinary Shares 24,000 Direct F1, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reported securities are represented by American Depositary Shares ("ADSs"), each of which represents eight (8) Ordinary Shares of the Issuer.
F2 Consists of 358,856 Ordinary Shares represented by 44,857 ADSs.
F3 Represents an award of Restricted Share Units ("RSUs") covering ADSs, which is presented in terms of the equivalent number of Ordinary Shares underlying the ADSs. Each RSU represents a contingent right to receive one (1) ADS of the Issuer. Each ADS represents eight (8) Ordinary Shares of the Issuer. The RSUs have no expiration date.
F4 The RSUs vest as to 25% of the total shares on each of August 1, 2025, November 1, 2025, February 1, 2026 and May 1, 2026 subject to the Reporting Person's continued service to the Issuer on each vesting date.

Remarks:

Exhibit 24 - Power of Attorney.